You may also like
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19
The present findings suggested that about half of adult patients with severe COVID-19–related ARDS can be managed successfully with ECMO with sustained results at six months. Decreased arterial pH before ECMO was associated significantly with early mortality. Therefore, the authors hypothesized that initiation of ECMO therapy before severe metabolic derangements subset may improve survival rates significantly in these patients. These results should be viewed in the light of a strict patient selection policy and may not be replicated in patients with advanced age or multiple comorbidities.
1 min read
SUNY Student and Resident Training: National Long-term Vision (EP Video)
Bruce Searles discusses the SUNY resident training program and their long-term vision (38:06 minutes).
1 min read
A Retrospective Analysis of CO2 Derived Goal-Directed Perfusion Variables Under Normothermic Conditions: Do We Need to Re-Evaluate Threshold Values?
Because CO2 production during bypass depends on patient temperature, a different cutoff value, that may take into account the influence of demographic variables, should be determined during normothermic CPB.
1 min read